AU5348098A - Melanocortins - Google Patents

Melanocortins

Info

Publication number
AU5348098A
AU5348098A AU53480/98A AU5348098A AU5348098A AU 5348098 A AU5348098 A AU 5348098A AU 53480/98 A AU53480/98 A AU 53480/98A AU 5348098 A AU5348098 A AU 5348098A AU 5348098 A AU5348098 A AU 5348098A
Authority
AU
Australia
Prior art keywords
msh
peptide
ala
peptides
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53480/98A
Other languages
English (en)
Inventor
Roger Antonius Henricus Adan
Johannes Peter Henri Burbach
Willem Hendrik Gispen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Holdings Cambridge Ltd
Original Assignee
RUDOLF MAGNUS INST FOR NEUROSC
SEED CAPITAL INVESTMENTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RUDOLF MAGNUS INST FOR NEUROSC, SEED CAPITAL INVESTMENTS filed Critical RUDOLF MAGNUS INST FOR NEUROSC
Publication of AU5348098A publication Critical patent/AU5348098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrane Compounds (AREA)
AU53480/98A 1996-12-17 1997-12-17 Melanocortins Abandoned AU5348098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96203567 1996-12-17
EP96203567.1 1996-12-17
PCT/NL1997/000703 WO1998027113A2 (fr) 1996-12-17 1997-12-17 Melanocortines

Publications (1)

Publication Number Publication Date
AU5348098A true AU5348098A (en) 1998-07-15

Family

ID=8224709

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53480/98A Abandoned AU5348098A (en) 1996-12-17 1997-12-17 Melanocortins

Country Status (6)

Country Link
EP (1) EP0946595A2 (fr)
JP (1) JP2001506996A (fr)
CN (1) CN1246868A (fr)
AU (1) AU5348098A (fr)
CA (1) CA2275442A1 (fr)
WO (1) WO1998027113A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2283564C (fr) * 1997-04-15 2007-07-10 Csir Compositions pharmaceutiques dotees d'une activite coupe-faim
ATE393783T1 (de) 1999-03-29 2008-05-15 Procter & Gamble Melanocortinrezeptor-liganden
GB2355657B (en) 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
WO2001030808A1 (fr) * 1999-10-27 2001-05-03 The Regents Of The University Of California Procedes et composes utiles pour moduler la liaison du recepteur de melanocortine-ligand
CA2396307A1 (fr) 2000-01-18 2001-07-26 Merck & Co., Inc. Peptides cycliques utilises comme antagonistes puissants et selectifs du recepteur de la melanocortine-4
GB0012370D0 (en) * 2000-05-22 2000-07-12 Quadrant Holdings Cambridge Peptoids
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
AU2002238106A1 (en) 2001-02-13 2002-08-28 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
AU2002322466B2 (en) 2001-07-11 2007-08-30 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
KR20060026011A (ko) 2003-05-09 2006-03-22 노보 노르디스크 에이/에스 비만 치료용 펩티드
MXPA06003474A (es) 2003-09-30 2006-06-05 Novo Nordisk As Agonistas de receptores de melanocortina.
CA2552043A1 (fr) 2004-01-21 2005-08-04 Novo Nordisk A/S Conjugaison de peptides induite par la transglutaminase
CN102131514B (zh) 2008-06-09 2014-08-20 帕拉丁科技公司 用于治疗性功能障碍的黑皮质素受体特异性肽
CN102458436B (zh) 2009-06-08 2015-06-03 帕拉丁科技公司 黑皮质素受体特异性肽
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
WO2010144341A2 (fr) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Peptides spécifiques des récepteurs aux mélanocortines à pont lactame
MX2012005859A (es) 2009-11-23 2012-12-17 Palatin Technologies Inc Peptidos lineales especificos del receptor de melanocortina-1.
EA021897B1 (ru) 2009-11-23 2015-09-30 Палатин Текнолоджиз, Инк. Циклические пептиды, специфичные к рецептору меланокортина-1
EP2513096A1 (fr) 2009-12-18 2012-10-24 Janssen Pharmaceutica, N.V. Aminothiazolone indazoles substitués comme modulateurs des récepteurs alpha liés aux strogènes
AU2011218268A1 (en) 2010-02-17 2012-09-06 Janssen Pharmaceutica Nv Aminothiazolones as estrogen related receptor-alpha modulators
MX2012009529A (es) 2010-02-17 2013-01-14 Janssen Pharmaceutica Nv Aminotiazolonas como moduladores de receptores alfa relacionados con el estrógeno.
US20130012432A1 (en) 2010-02-26 2013-01-10 Novo Nordisk A/S Peptides for Treatment of Obesity
BR112012021231A2 (pt) 2010-02-26 2015-09-08 Basf Plant Science Co Gmbh método para acentuar o rendimento em plantas, planta, construto, uso de um construto, método para a produção de uma planta transgênica, partes coletáveis de uma planta, produtos derivados de uma planta, uso de um ácido nucleíco e método para a produção de um produto
WO2011149841A1 (fr) 2010-05-25 2011-12-01 Janssen Pharmaceutica Nv Thiazolidinedione indazoles, indoles et benzotriazoles substitués utiles en tant que modulateurs des récepteurs α liés aux œstrogènes
CN104822702B (zh) 2012-10-19 2019-07-30 Txp制药股份有限公司 α-MSH和γ-MSH类似物
BR112016024494B1 (pt) 2014-04-22 2024-02-06 Txp Pharma Gmbh Análogo de peptídeo e seu uso
EP3596107A1 (fr) 2017-03-15 2020-01-22 Novo Nordisk A/S Composés bicycliques aptes à se lier au récepteur de mélanocortine 4
US20210221867A1 (en) 2018-05-15 2021-07-22 Novo Nordisk A/S Compounds Capable of Binding to Melanocortin 4 Receptor
WO2020053414A1 (fr) 2018-09-14 2020-03-19 Novo Nordisk A/S Composés bicycliques aptes à se lier aux agonistes du récepteur de la mélanocortine 4

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022460A1 (fr) * 1993-04-05 1994-10-13 University Patents, Inc. Diagnostic et traitement des dysfonctionnements erectiles

Also Published As

Publication number Publication date
CN1246868A (zh) 2000-03-08
WO1998027113A8 (fr) 1999-09-02
CA2275442A1 (fr) 1998-06-25
WO1998027113A3 (fr) 1998-08-06
WO1998027113A2 (fr) 1998-06-25
WO1998027113A9 (fr) 1999-11-04
JP2001506996A (ja) 2001-05-29
EP0946595A2 (fr) 1999-10-06

Similar Documents

Publication Publication Date Title
AU5348098A (en) Melanocortins
US8022035B2 (en) Y4 selective receptor agonists for therapeutic interventions
KR101232201B1 (ko) 멜라노코르틴 수용체 리간드
Starowicz et al. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception
JP2744910B2 (ja) ペプチド誘導体類
US7851590B2 (en) Y2 selective receptor agonists for therapeutic interventions
AU2005224027B2 (en) Y2/Y4 selective receptor agonists for therapeutic interventions
EP2060266A1 (fr) Agonistes du récepteur de sélection Y4 pour interventions thérapeutiques
US7084111B2 (en) Melanocortin receptor templates, peptides, and use thereof
Grieco et al. Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6
US5614370A (en) Assay to identify human C5a antagonists and agonists
EP2427204B1 (fr) Conjugués se liant au récepteur de la mélanocortine
DE69225597T2 (de) Peptide mit einer lanthionin-brücke
Katsoulis et al. Effects of galanin, its analogues and fragments on rat isolated fundus strips
EP0101929A1 (fr) Diesters de polypeptides, leur production et utilisation
CH654841A5 (de) Appetitzuegelnde tripeptide und verfahren zur herstellung derselben.
EP1025127A1 (fr) Peptides cycliques selectifs vis-a-vis de sous-types de recepteurs msh
JPH0940699A (ja) ポリペプチド及びその用途
EP0434722A1 (fr) Nouveau pentapeptide et son procede de preparation
FI68245C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva polypeptidderivat eller syraadditionssalter daerav
KR20020038400A (ko) 디썰파이드로 결합되는 환펩타이드형 화합물
Ramachandran Structural and functional interrelationships of adrenocorticotropin and the melanotropins
AU2001271657A1 (en) I-superfamily conotoxins
AU3223500A (en) Tau-conotoxin peptides
City et al. Walker et al.(45) Date of Patent: Oct. 7, 2003

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted